Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL
NCT03706248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65
Last updated 2020-02-13
Summary
To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in subjects with colorectal cancer that have documented recurrence or no evidence of recurrence by CT.
Conditions
Interventions
- OTHER
-
Blood Draw
20 ml of blood will be drawn from subjects via venipuncture
Sponsors & Collaborators
-
Clinical Genomics Pathology
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-28
- Primary Completion
- 2019-07-15
- Completion
- 2019-07-15
Countries
- United States
Study Locations
More Related Trials
-
Early Detection and Risk Stratification of Colorectal Cancer Based on miRNA Platform
NCT06351384 ·Status: NOT_YET_RECRUITING
-
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
NCT00625625 ·Status: UNKNOWN ·Phase: PHASE2
-
Genetic Study of Patients and Families With a History of Colorectal Cancer
NCT00003648 ·Status: COMPLETED
-
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
NCT03821948 ·Status: COMPLETED
-
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
NCT06889883 ·Status: RECRUITING
-
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT06620627 ·Status: RECRUITING
-
Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer
NCT01479894 ·Status: COMPLETED
-
Ga-68-FAPI-46 PET for CRC Recurrence Detection in Elevated CEA
NCT06769828 ·Status: RECRUITING ·Phase: NA
-
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer
NCT03251612 ·Status: COMPLETED ·Phase: PHASE2
-
Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
NCT05068531 ·Status: RECRUITING
-
Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer
NCT05475288 ·Status: COMPLETED
-
Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
NCT00582829 ·Status: COMPLETED
-
Screening Tests in Detecting Colorectal Cancer
NCT00025025 ·Status: COMPLETED
-
Early-Onset Colorectal Cancer Recurrence
NCT06271980 ·Status: COMPLETED
-
Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
NCT00410579 ·Status: COMPLETED
-
SMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReening
NCT06714318 ·Status: RECRUITING
-
A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein Blood
NCT06524245 ·Status: RECRUITING
-
Survey of ColoRectal Cancer Education and Environment Needs
NCT00229554 ·Status: COMPLETED
-
Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer
NCT05129046 ·Status: RECRUITING
-
Gene Testing in Patients With Colon Cancer
NCT00003571 ·Status: COMPLETED
-
Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
NCT06696534 ·Status: RECRUITING ·Phase: NA
-
Colon Cancer Treatment Decisions and Recurrence Predicting
NCT02997241 ·Status: UNKNOWN ·Phase: NA
-
the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer
NCT05131243 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment
NCT02813928 ·Status: COMPLETED ·Phase: NA
-
Evaluating Strategies to Present Colon Cancer Screening Information
NCT02485561 ·Status: COMPLETED ·Phase: NA